The CD15 test is a diagnostic laboratory evaluation used in hematopathology to detect expression of the CD15 cell-surface carbohydrate antigen (3-fucosyl-N-acetyllactosamine). Expressed prominently on mature neutrophils, eosinophils, and monocytes, CD15 serves as an important marker in immunophenotyping.
Conducted via immunohistochemistry or flow cytometry on blood, bone marrow, or tissue biopsies, this test is critical for diagnosing Classical Hodgkin Lymphoma, where CD15 is typically positive on characteristic Reed-Sternberg cells. It also aids in identifying granulocytic differentiation in Acute Myeloid Leukemia (AML). Evaluating CD15 expression assists clinicians in accurate cancer subtyping, staging, and determining optimal targeted therapies.

A Complete Blood Count (CBC) and Peripheral Blood Smear test provide a comprehensive evaluation of your blood's health and cellular structure. The CBC quantifies key components, including red blood cells, white blood cells, hemoglobin, and platelets, to screen for conditions like anemia, infections, and clotting disorders. Complementing this, the peripheral blood smear involves examining a thin layer of blood under a microscope to evaluate the size, shape, and appearance of these cells. Together, these complementary diagnostic tests offer critical insights, helping clinicians identify abnormal cell morphology, detect underlying blood disorders, and effectively guide targeted medical care.

A Carrier Screening Panel for an individual, or solo test, is a vital genetic assessment for anyone planning a family without partner testing or prior family history. It analyzes a person's DNA to identify if they carry recessive gene mutations for severe genetic conditions, including cystic fibrosis, spinal muscular atrophy, or sickle cell anemia. Because carriers typically experience no health symptoms themselves, this test provides essential clarity regarding hidden genetic risks. Identifying single-carrier status enables individuals to proactively discuss future family planning with their partners, seek guidance from genetic counselors, and make fully informed reproductive decisions before pregnancy.

A Carrier Screening Panel for couples is a specialized genetic test designed for prospective parents planning a family. It determines if both partners carry gene mutations for the same inherited recessive disorders, such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome. Even if both individuals are healthy, carrying the same mutation means there is a 25% risk per pregnancy of passing the condition to their child. By identifying these potential genetic risks beforehand, couples gain vital reproductive insights, enabling them to explore proactive family-planning options, consult expert genetic counselors, and make informed, empowered medical decisions with total confidence.

The Cardiolipin Antibody (ACL) - IgM Test is a diagnostic blood test used to detect and measure the levels of IgM class antibodies directed against cardiolipin, a crucial phospholipid found in cell membranes. This test is a key component in the evaluation of Antiphospholipid Syndrome (APS), an autoimmune disorder associated with an increased risk of blood clots (thrombosis) in arteries and veins, as well as pregnancy complications like recurrent miscarriages. While IgG antibodies are more commonly associated with APS, testing for IgM provides additional diagnostic sensitivity, especially in acute phases of the condition. The result helps clinicians assess a patient’s risk profile.

The Cardiolipin Antibody (ACL) - IgG Test is a crucial diagnostic blood test used to detect and quantify IgG class antibodies directed against cardiolipin, a key phospholipid found in cell membranes. This test is a primary tool in the diagnosis of Antiphospholipid Syndrome (APS), an autoimmune disorder characterized by unexplained blood clotting (thrombosis) and pregnancy-related complications, such as recurrent miscarriages. Elevated levels of IgG-type ACL antibodies are strongly associated with the risk of these thrombotic events. The test is often ordered alongside IgM and IgA isotypes to provide a comprehensive profile for APS assessment and management.

The Cardiolipin Antibody (ACL) - IgA Test is a specialized blood test used to detect IgA class antibodies directed against cardiolipin, a vital phospholipid found in cell membranes.
This test is primarily ordered to aid in the diagnosis of Antiphospholipid Syndrome (APS), an autoimmune disorder characterized by abnormal blood clotting in arteries and veins, as well as recurrent pregnancy complications. While IgG and IgM are the most common isotypes tested, checking for IgA antibodies provides additional diagnostic value, especially in patients with clinical symptoms of APS who test negative for other markers. It helps physicians assess thrombotic risk accurately.

The Cardiac Risk Marker Test is an advanced diagnostic panel designed to evaluate an individual's long-term likelihood of developing cardiovascular disease or experiencing a heart attack.
Unlike standard lipid profiles, this specialized test measures specific blood biomarkers—such as High-Sensitivity C-Reactive Protein (hs-CRP), Lipoprotein(a), Homocysteine, and Apolipoproteins—which detect hidden inflammation, plaque instability, and genetic predispositions to arterial blockage.
It is especially valuable for individuals with a family history of heart disease, normal cholesterol levels but unexplained cardiac events, or chronic conditions like diabetes. This crucial test enables early, targeted preventive interventions.

The Cardiac Profile - IPD Package is an all-inclusive, in-patient hospital program meticulously designed for individuals requiring intensive cardiac assessment, stabilization, or post-procedure monitoring.
Tailored for patients with acute conditions like unstable angina, recent heart failure exacerbation, or those recovering from interventions such as angioplasty or bypass surgery, this package bundles essential services for a seamless care experience. It typically includes 24/7 nursing care in a cardiac ward, continuous telemetry monitoring, daily consultant visits, comprehensive laboratory work, advanced imaging (like Echocardiograms), and pharmacy support.
By consolidating these critical services, the IPD package ensures coordinated, high-quality care, promotes faster recovery, and provides peace of mind for patients and their families during a hospital stay.

The Cardiac Profile - OPD Package is a comprehensive outpatient health check designed for the early detection, evaluation, and prevention of cardiovascular diseases.
Tailored for individuals with risk factors such as high blood pressure, diabetes, stress, or a family history of heart conditions, this screening bundle typically includes vital diagnostic evaluations like an Electrocardiogram (ECG), Lipid Profile, Fasting Blood Sugar, and a cardiologist consultation.
By assessing key markers of heart health efficiently in a single visit, this package empowers patients to proactively manage their wellness, prevent critical cardiac events, and ensure long-term vitality.

The Cardiac Profile M test is a comprehensive blood package designed to evaluate overall heart health and assess cardiovascular disease risks. Typically consisting of multiple key parameters, this panel combines a complete lipid profile—measuring cholesterol components like HDL, LDL, and triglycerides—with critical cardiac risk markers. By analyzing these specific biochemical indicators, the test helps clinicians identify hidden vulnerabilities, monitor cholesterol management, and detect early signs of potential heart conditions. It serves as a valuable diagnostic tool for preventive health screenings, enabling timely interventions and personalized lifestyle or therapeutic strategies to protect long-term cardiac wellness.

The Cardiac Profile C test is an advanced, comprehensive diagnostic evaluation designed to provide an in-depth analysis of cardiovascular health and intricate heart disease risks. Building upon standard and intermediate screenings, this specialized panel frequently includes high-sensitivity cardiac markers, advanced lipid fractionations, genetic or inflammatory indicators, and specialized coagulation factors. By detecting subtle vascular inflammation, micro-vascular stress, and precise lipoprotein particle sizes, the Cardiac Profile C test offers clinicians granular insight into a patient's long-term wellness. This high-resolution diagnostic tool enables fully personalized preventive strategies, early intervention, and optimized therapeutic management for long-term cardiac protection.